Loading…

Engulfment and cannibalism drive persistence of chemotherapy-treated tumor cells: can they be targeted?

The breast tumors that are most difficult to eradicate with chemotherapy have wild-type TP53 and preferentially enter senescence after treatment. One factor contributing to the persistence of senescent cells in residual disease: acquisition of a novel phenotype that allows cannibalism of entire cell...

Full description

Saved in:
Bibliographic Details
Published in:Molecular & cellular oncology 2020-01, Vol.7 (1), p.1688601-1688601
Main Authors: Tonnessen-Murray, Crystal A., Jackson, James G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The breast tumors that are most difficult to eradicate with chemotherapy have wild-type TP53 and preferentially enter senescence after treatment. One factor contributing to the persistence of senescent cells in residual disease: acquisition of a novel phenotype that allows cannibalism of entire cells and engulfment of other substrates.
ISSN:2372-3556
2372-3556
DOI:10.1080/23723556.2019.1688601